A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Public ClinicalTrials.gov record NCT07116616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Study identification
- NCT ID
- NCT07116616
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- ModernaTX, Inc.
- Industry
- Enrollment
- 166 participants
Conditions and interventions
Conditions
Interventions
- mRNA-2808 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2025
- Primary completion
- Jun 16, 2030
- Completion
- Jun 16, 2032
- Last update posted
- Apr 2, 2026
2025 – 2032
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Hospital | Birmingham | Alabama | 35233 | Recruiting |
| UCSF | San Francisco | California | 94143 | Not yet recruiting |
| Emory University Hospital | Atlanta | Georgia | 30322 | Recruiting |
| Mass General Brigham | Boston | Massachusetts | 02114 | Not yet recruiting |
| Tisch Cancer Institute at Mount Sinai | New York | New York | 10029 | Recruiting |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | Not yet recruiting |
| Atrium Health Levine Cancer Institute | Charlotte | North Carolina | 28204 | Not yet recruiting |
| Penn Medicine | Philadelphia | Pennsylvania | 19104 | Not yet recruiting |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | Recruiting |
| The Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07116616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07116616 live on ClinicalTrials.gov.